The deal is expected to close in the first quarter of 2023, LG Chem said.
(Reporting by Joyce Lee; Editing by Kirsten Donovan)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
403,500 KRW | -0.37% | +2.02% | -19.14% |
May. 02 | LG Chem's Profit Plunges in Q1 | MT |
May. 02 | LG Chem, Alkhorayef Group Collaborate to Offer Advanced Water Solutions in Saudi Arabia | MT |
SEOUL (Reuters) - South Korea's LG Chem Ltd said in a regulatory filing on Tuesday that it is investing $566 million to acquire U.S. firm Aveo Pharmaceuticals Inc and enter the U.S. anti-cancer drug market.
The deal is expected to close in the first quarter of 2023, LG Chem said.
(Reporting by Joyce Lee; Editing by Kirsten Donovan)
1st Jan change | Capi. | |
---|---|---|
-19.14% | 22.48B | |
+4.56% | 40.32B | |
-12.88% | 13.59B | |
-9.31% | 10.22B | |
-8.73% | 9.67B | |
+15.51% | 8.02B | |
+13.14% | 7.09B | |
-23.90% | 5.8B | |
-29.24% | 3.37B | |
-21.77% | 3.32B |